Pharmacologic properties of a new oral contrast medium for cholecystography.
D000081:Acetamides / Q000008:administration & dosage / Q000633:toxicity; D000284:Administration, Oral; D000818:Animals; D001646:Bile / Q000378:metabolism; D001659:Biliary Tract / Q000378:metabolism; D002415:Cats; D002765:Cholecystography; D003287:Contrast Media / Q000008:administration & dosage / Q000378:metabolism / Q000633:toxicity; D004285:Dogs; D004987:Ethers / Q000008:administration & dosage / Q000633:toxicity; D007275:Injections, Intravenous; D007408:Intestinal Absorption / Q000187:drug effects; D007462:Iodobenzenes / Q000008:administration & dosage / Q000633:toxicity; D007480:Iopanoic Acid; D007487:Ipodate; D007928:Lethal Dose 50; D051379:Mice; D011422:Propionates / Q000008:administration & dosage / Q000633:toxicity; D011485:Protein Binding; D011817:Rabbits; D051381:Rats; D013997:Time Factors
D000081:Acetamides; D003287:Contrast Media; D004987:Ethers; D007462:Iodobenzenes; D011422:Propionates; D007487:Ipodate; D007480:Iopanoic Acid